Le Lézard
Classified in: Business, Sports and recreation, Covid-19 virus
Subject: ERN

Smith & Wesson Brands, Inc. Reports Fourth Quarter and Full Year Fiscal 2021 Financial Results


SPRINGFIELD, Mass., June 17, 2021 /PRNewswire/ -- Smith & Wesson Brands, Inc. (NASDAQ Global Select: SWBI), a U.S.-based leader in firearm manufacturing and design, today announced financial results for the fourth quarter and full fiscal year 2021, ended April 30, 2021.  On August 24, 2020, the company completed the previously announced spin-off of its outdoor products and accessories business.  Therefore, as of the second quarter, all historical financial information for that business is reported as discontinued operations.  Unless otherwise indicated, any reference to income statement items refers to results from continuing operations.

Fourth Quarter Fiscal 2021 Financial Highlights

Full year Fiscal 2021 Financial Highlights

Mark Smith, President and Chief Executive Officer, commented, "The results of the past year, in spite of the unthinkable challenges that we faced as a nation and as a company, are a tremendous testament to the resolve of our dedicated employees, the power of the Smith & Wesson brand, and the strength of the partnerships we have with our customers. Our employees more than doubled the prior year sales, passed a milestone of $1 billion in revenue, and by every financial and operating metric, have delivered the most successful year in the 169 year history of the company. But most importantly, we have set a rock solid foundation for the long term success of the company, with astounding market share growth. During the past fiscal year, the US firearms market experienced record growth of 42%, meanwhile shipments from Smith & Wesson far surpassed the industry, growing by 70%. Strong consumer preference for our products combined with our ability to rapidly react to the increased demand has placed us in a clear leadership position as we enter into our first full fiscal year as a standalone pure-play firearms company."

Deana McPherson, Executive Vice President and Chief Financial Officer, commented, "The hard work and dedication of all of our employees, combined with record-breaking demand for our high-quality products drove equally record-breaking financial results for the year, including record revenue, net income, earnings per share, and cash generation. We began our first year as a pure-play firearm company with clear strategic priorities, and we have delivered on our strategy.  During fiscal 2021, we invested in our business and our people, we repaid all of our bank debt, we repurchased over 10% of our outstanding common stock, and we began paying our stockholders a quarterly dividend for the first time in company history.  Continuing  with our capital allocation strategy, I am pleased to announce that our Board has authorized a new $50 million share repurchase program as well as a 60% increase in our quarterly dividend to 8 cents per share.  This quarter's dividend will be paid to stockholders of record on July 1st with payment to be made on July 6th."

The amount and timing of any repurchases will depend on a number of factors, including price, trading volume, general market conditions, legal requirements, and other factors.  The repurchases may be made on the open market, in block trades, or in privately negotiated transactions. Any shares of common stock repurchased under the program will be considered issued but not outstanding shares of the company's common stock. 

Conference Call and Webcast
The company will host a conference call and webcast on June 17, 2021, to discuss its fourth quarter and full fiscal 2021 financial and operational results. Speakers on the conference call will include Mark Smith, President and Chief Executive Officer, and Deana McPherson, Executive Vice President and Chief Financial Officer. The conference call may include forward-looking statements. The conference call and webcast will begin at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time). Those interested in listening to the conference call via telephone may call directly at (844) 309-6568 and reference conference identification number 1173799.  No RSVP is necessary. The conference call audio webcast can also be accessed live on the company's website at www.smith-wesson.com, under the Investor Relations section.

Reconciliation of U.S. GAAP to Non-GAAP Financial Measures
In this press release, certain non-GAAP financial measures, including "non-GAAP net income," "Adjusted EBITDAS," and "free cash flow" are presented. From time-to-time, the company considers and uses these supplemental measures of operating performance in order to provide the reader with an improved understanding of underlying performance trends.  The company believes it is useful for itself and the reader to review, as applicable, both (1) GAAP measures that include (i) amortization of acquired intangible assets, (ii) transition costs, (iii) change in contingent consideration, (iv) CEO separation, (v) the tax effect of non-GAAP adjustments, and (vi) COVID-19 expenses; and (2) the non-GAAP measures that exclude such information. The company presents these non-GAAP measures because it considers them an important supplemental measure of its performance. The company's definition of these adjusted financial measures may differ from similarly named measures used by others. The company believes these measures facilitate operating performance comparisons from period to period by eliminating potential differences caused by the existence and timing of certain expense items that would not otherwise be apparent on a GAAP basis.  These non-GAAP measures have limitations as an analytical tool and should not be considered in isolation or as a substitute for the company's GAAP measures.  The principal limitations of these measures are that they do not reflect the company's actual expenses and may thus have the effect of inflating its financial measures on a GAAP basis.

About Smith & Wesson Brands, Inc.
Smith & Wesson Brands, Inc. (NASDAQ Global Select: SWBI) is a U.S.-based leader in firearm manufacturing and design, delivering a broad portfolio of quality handgun, long gun, and suppressor products to the global consumer and professional markets under the iconic Smith & Wesson®, M&P®, and Gemtech® brands.  The company also provides manufacturing services including forging, machining, and precision plastic injection molding services.  For more information call (844) 363-5386 or visit www.smith-wesson.com.

Safe Harbor Statement
Certain statements contained in this press release may be deemed to be forward-looking statements under federal securities laws, and we intend that such forward-looking statements be subject to the safe-harbor created thereby. Such forward-looking statements include, among others, our belief that we have set a rock solid foundation for the long-term success of the company, with astounding market share growth; and our belief that strong consumer preference for our products combined with our ability to rapidly react to the increased demand has placed us in a clear leadership position as we enter into our first full fiscal year as a standalone pure-play firearms company. We caution that these statements are qualified by important risks, uncertainties, and other factors that could cause actual results to differ materially from those reflected by such forward-looking statements. Such factors include, among others, economic, social, political, legislative, and regulatory factors; the potential for increased regulation of firearms and firearm-related products; actions of social activists that could have an adverse effect on our business; the impact of lawsuits; the demand for our products; the state of the U.S. economy in general and the firearm industry in particular; general economic conditions and consumer spending patterns; our competitive environment; the supply, availability, and costs of raw materials and components; our anticipated growth and growth opportunities; our strategies; our ability to maintain and enhance brand recognition and reputation; our ability to introduce new products; the success of new products; the potential for cancellation of orders from our backlog; and other risks detailed from time to time in our reports filed with the Securities and Exchange Commission, including our Annual Report on Form 10-K for the fiscal year ended April 30, 2021.

Contact:
[email protected]
(413) 747-3448

SMITH & WESSON BRANDS, INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS



As of:


April 30, 2021


April 30, 2020


(In thousands, except par value and share data)

 ASSETS

 Current assets:




Cash and cash equivalents

$   113,017


$   125,011

Accounts receivable, net of allowances for credit losses of $107 on April 30, 2021 and $1,038 on April 30, 2020

67,442


60,879

Inventories

78,477


103,741

Prepaid expenses and other current assets

8,408


7,556

Current assets of discontinued operations

?


94,673

Income tax receivable 

909


1,595

Total current assets

268,253


393,455

 Property, plant, and equipment, net

141,612


147,739

 Intangibles, net

4,417


4,375

 Goodwill

19,024


19,024

 Other assets of discontinued operations

?


148,485

 Other assets

13,082


16,437


446,388


729,515

 LIABILITIES AND STOCKHOLDERS' EQUITY

 Current liabilities:




Accounts payable

$     57,337


$     31,476

Accrued expenses and deferred revenue

33,136


57,678

Accrued payroll and incentives

17,381


12,448

Accrued income taxes

1,157


5,503

Accrued profit sharing

14,445


2,197

Accrued warranty

2,199


3,297

Current liabilties of discontinued operations

?


17,372

Total current liabilities

125,655


129,971

 Deferred income taxes 

904


457

 Notes and loans payable, net of current portion

?


159,171

 Finance lease payable, net of current portion

38,786


39,873

Other non-current liabilities of discontinued operations

?


2,299

Other non-current liabilities

14,659


10,626

Total liabilities

180,004


342,397

 Commitments and contingencies




 Stockholders' equity:




Preferred stock, $.001 par value, 20,000,000 shares authorized, no shares issued or outstanding

?


?

Common stock, $.001 par value, 100,000,000 shares authorized, 74,222,127 issued and 49,937,329 shares outstanding on April 30, 2021 and 73,526,790 shares issued and 55,359,928 shares outstanding on April 30, 2020

74


74

Additional paid-in capital 

273,431


267,630

Retained earnings

325,181


341,716

Accumulated other comprehensive income

73


73

Treasury stock, at cost (24,284,798 shares on April 30, 2021 and 18,166,862 on April 30, 2020)

(332,375)


(222,375)

Total stockholders' equity

266,384


387,118


$   446,388


$   729,515

 

SMITH & WESSON BRANDS, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF INCOME/(LOSS)










For the Three Months Ended April 30,


For the Years Ended April 30,


2021


2020


2021


2020


(Unaudited)






(In thousands, except per share data)

Net sales

$322,947


$193,045


$1,059,195


$529,618

Cost of sales

177,139


130,941


610,212


363,929

Gross profit

145,808


62,104


448,983


165,689

Operating expenses:








Research and development

1,963


1,863


7,480


7,364

Selling, marketing, and distribution

10,507


11,148


42,603


41,987

General and administrative

17,207


18,119


79,268


66,033

Total operating expenses

29,677


31,130


129,351


115,384

Operating income from continuing operations

116,131


30,974


319,632


50,305

Other income/(expense), net:








Other income/(expense), net 

540


67


2,252


495

Interest expense, net

(563)


(2,705)


(3,919)


(11,625)

Total other (expense)/income, net

(23)


(2,638)


(1,667)


(11,130)

Income from operations before income taxes

116,108


28,336


317,965


39,175

Income tax expense

26,929


7,438


74,394


11,522

Income from continuing operations

$   89,179


$   20,898


$    243,571


$   27,653

Discontinued operations:








(Loss)/income from discontinued operations

(144)


(87,044)


8,478


(88,883)

Net income/(loss)

$   89,035


$ (66,146)


$    252,049


$ (61,230)









Net income/(loss) per share:








Basic - continuing operations

$       1.72


$       0.38


$           4.46


$       0.50

Basic - net income/(loss)

$       1.72


$      (1.20)


$           4.62


$      (1.11)

Diluted - continuing operations

$       1.70


$       0.38


$           4.40


$       0.50

Diluted - net income/(loss)

$       1.70


$      (1.20)


$           4.55


$      (1.10)

Weighted average number of common shares outstanding:








Basic

51,816


54,983


54,613


54,983

Diluted

52,423


54,983


55,352


55,665

 

SMITH & WESSON BRANDS, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS






For the Year Ended


April 30, 2021


April 30, 2020


(In thousands)

Cash flows from operating activities:




Income from continuing operations

$      243,571


$        27,653

Adjustments to reconcile net income to net cash provided by operating activities:




Depreciation and amortization 

31,575


31,972

(Gain)/loss on sale/disposition of assets

154


419

Provision for losses on notes and accounts receivable

(739)


(585)

Deferred income taxes

447


(260)

Change in fair value of contingent consideration

?


100

Stock-based compensation expense

4,706


2,357

Changes in operating assets and liabilities:




     Accounts receivable

(5,824)


(198)

     Inventories

25,264


(911)

     Prepaid expenses and other current assets

(852)


(3,124)

     Income taxes

(3,643)


6,196

     Accounts payable

25,540


4,043

     Accrued payroll and incentives

4,933


(5,831)

     Accrued profit sharing

12,248


(355)

     Accrued expenses and deferred revenue

(24,633)


21,755

     Accrued warranty

(1,098)


(1,126)

     Other assets

1,579


1,131

     Other non-current liabilities

4,032


(2,401)

     Cash provided by operating activities - continuing operations

317,260


80,835

     Cash (used in)/provided by operating activities - discontinued operations

(1,926)


13,901

Net cash provided by operating activities

315,334


94,736

Cash flows from investing activities:




Refunds on machinery and equipment

310


?

Receipts from note receivable

?


786

Payments to acquire patents and software

(632)


(429)

Proceeds from sale of property and equipment

113


?

Payments to acquire property and equipment

(22,052)


(12,441)

Cash used by investing activities - continuing operations

(22,261)


(12,084)

Cash used by investing activities - discontinued operations

(1,143)


(1,874)

Net cash used in investing activities

(23,404)


(13,958)

Cash flows from financing activities:




Proceeds from loans and notes payable

25,000


228,225

Cash paid for debt issuance costs

(450)


(875)

Payments on finance lease obligation

(996)


(900)

Payments on notes and loans payable

(185,000)


(224,600)

Distribution to AOUT

(25,000)


?

Payments to acquire treasury stock

(110,000)


?

Dividend distribution

(8,223)


?

Proceeds from exercise of options to acquire common stock, including employee stock repurchase plan

3,154


2,127

Payment of employee withholding tax related to restricted stock units

(2,243)


(597)

Cash (used in)/provided by financial activities - continuing operations

(303,758)


3,380

Cash used in financial activities - discontinued operations

(166)


?

Net cash (used in)/provided by financing activities

(303,924)


3,380

Net (decrease)/increase in cash and cash equivalents

(11,994)


84,158

Cash and cash equivalents, beginning of period

125,011


40,853

Cash and cash equivalents, end of period

$      113,017


$      125,011

Supplemental disclosure of cash flow information




Cash paid for:




Interest

$          3,306


$        11,103

Income taxes

$        80,874


$          6,935

 

SMITH & WESSON BRANDS, INC. AND SUBSIDIARIES

RECONCILIATION OF GAAP FINANCIAL MEASURES TO NON-GAAP FINANCIAL MEASURES

(Dollars in thousands, except per share data)

(Unaudited)


For the Three Months Ended 


For the Year Ended


April 30, 2021


April 30, 2020


April 30, 2021


April 30, 2020


$


% of Sales


$


% of Sales


$


% of Sales


$


% of Sales

GAAP gross profit

$ 145,808


45.1%


$ 62,104


32.2%


$  448,983


42.4%


$ 165,689


31.3%

COVID-19

43


0.0%


1,899


1.0%


560


0.1%


1,899


0.4%

Non-GAAP gross profit

$ 145,851


45.2%


$ 64,003


33.2%


$  449,543


42.4%


$ 167,588


31.6%

















GAAP operating expenses

$   29,677


9.2%


$ 31,130


16.1%


$  129,351


12.2%


$ 115,384


21.8%

Amortization of acquired intangible assets

(83)


0.0%


(86)


0.0%


(332)


0.0%


(345)


-0.1%

Transition costs

(22)


0.0%


(4,292)


-2.2%


(7,975)


-0.8%


(5,481)


-1.0%

COVID-19

(67)


0.0%


(460)


-0.2%


(685)


-0.1%


(460)


-0.1%

Spin related stock-based compensation

(296)


-0.1%


?


?


(738)


-0.1%


?


?

CEO separation

?


?


(2,252)


-1.2%


?


?


2,002


0.4%

Non-GAAP operating expenses

$   29,209


9.0%


$ 24,040


12.5%


$  119,621


11.3%


$ 111,100


21.0%

















GAAP operating income

$ 116,131


36.0%


$ 30,974


16.0%


$  319,632


30.2%


$   50,305


9.5%

Amortization of acquired intangible assets

83


0.0%


86


0.0%


332


0.0%


345


0.1%

Transition costs

22


0.0%


4,292


2.2%


7,975


0.8%


5,481


1.0%

COVID-19

110


0.0%


2,359


1.2%


1,245


0.1%


2,359


0.4%

Spin related stock-based compensation

296


0.1%


?


?


738


0.1%


?


?

CEO separation

?


?


2,252


1.2%


?


?


(2,002)


-0.4%

Non-GAAP operating income

$ 116,642


36.1%


$ 39,963


20.7%


$  329,922


31.1%


$   56,488


10.7%

















GAAP income from continuing operations

$   89,179


27.6%


$ 20,898


10.8%


$  243,571


23.0%


$   27,653


5.2%

Amortization of acquired intangible assets

83


0.0%


86


0.0%


332


0.0%


345


0.1%

Transition costs

22


0.0%


4,292


2.2%


7,975


0.8%


5,481


1.0%

COVID-19

110


0.0%


2,359


1.2%


1,245


0.1%


2,359


0.4%

Change in contingent consideration

?


?


?


?


?


?


(100)


0.0%

Spin related stock-based compensation

296


0.1%


?


?


738


0.1%


?


?

CEO separation

?


?


2,252


1.2%


?


?


(2,002)


-0.4%

Tax effect of non-GAAP adjustments

(119)


0.0%


(2,427)


-1.3%


(2,400)


-0.2%


(1,642)


-0.3%

Non-GAAP income from continuing operations

$   89,571


27.7%


$ 27,460


14.2%


$  251,461


23.7%


$   32,094


6.1%

















GAAP income from continuing operations per share - diluted

$        1.70




$      0.38




$         4.40




$        0.50



Amortization of acquired intangible assets

?




?




0.01




0.01



Transition costs

?




0.08




0.14




0.10



COVID-19

?




0.04




0.02




0.04



Change in contingent consideration

?




?




?




?



Spin related stock-based compensation

0.01




?




0.01




?



CEO separation

?




0.04




?




(0.04)



Tax effect of non-GAAP adjustments

?




(0.04)




(0.04)




(0.03)



Non-GAAP income from continuing operations per share - diluted

$        1.71




$      0.50




$         4.54




$        0.58



 

SMITH & WESSON BRANDS, INC. AND SUBSIDIARIES

RECONCILIATION OF OPERATING CASH FLOW FROM CONTINUING OPERATIONS TO FREE CASH FLOW

(In thousands)

(Unaudited)


For the Three Months Ended


For the Year Ended


April 30, 2021


April 30, 2020


April 30, 2021


April 30, 2020

Net cash provided by in operating activities

$   118,823


$   107,472


$   317,260


$     80,835

Net cash used in investing activities

(3,691)


(1,277)


(22,261)


(12,084)

Receipts from note receivable

?


(786)


?


(786)

Free cash flow

$   115,132


$   105,409


$   294,999


$     67,965

 

SMITH & WESSON BRANDS, INC. AND SUBSIDIARIES

RECONCILIATION OF GAAP INCOME FROM CONTINUING OPERATIONS TO NON-GAAP ADJUSTED EBITDAS 

(in thousands)

(Unaudited)










For the Three Months Ended


For the Year Ended


April 30, 2021


April 30, 2020


April 30, 2021


April 30, 2020









GAAP income from continuing operations

$          89,179


$          20,898


$       243,571


$         27,653

Interest expense

585


2,663


4,056


11,625

Income tax expense

26,929


11,522


74,394


11,522

Depreciation and amortization

7,420


7,433


30,685


31,209

Stock-based compensation expense

1,314


1,416


4,706


2,357

Change in contingent consideration

?


?


?


(100)

COVID-19

110


2,359


1,245


2,359

Transition costs

22


4,292


7,975


5,481

CEO separation

?


1,037


?


627

Non-GAAP Adjusted EBITDAS

$        125,559


$          51,620


$       366,632


$         92,733

 

SOURCE Smith & Wesson Brands, Inc.


These press releases may also interest you

at 01:20
Biophytis SA (Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specialized in thedevelopment oftherapeutics for age-related diseases, today annouces that it will change the ratio...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The economic turmoil triggered by the COVID-19 pandemic has led to a sharp decrease in the number of self-employed individuals in the United States, with a 22% reduction...

18 avr 2024
WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of QuidelOrtho Corporation between February 18, 2022 and April 1, 2024, both dates inclusive (the "Class...

18 avr 2024
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...



News published on and distributed by: